Partial lipodystrophy and familial C3 deficiency

Human Heredity

Volumn 30, Issue 3, 1980, Pages 149-154

  McLean, Robert H ^a,b   Hoefnagel, D ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Complement; Familial C3 deficiency; Glomerulonephritis; Partial lipodystrophy

Indexed keywords

COMPLEMENT COMPONENT C3;

BLOOD AND HEMOPOIETIC SYSTEM; CASE REPORT; COMPLEMENT DEFICIENCY; DIAGNOSIS; GLOMERULONEPHRITIS; HEREDITY; LIPODYSTROPHY; SOFT TISSUE;

COMPLEMENT 3; FEMALE; HUMAN; LIPODYSTROPHY; MALE; PEDIGREE; PHENOTYPE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018907240     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000153119     Document Type: Article

References (16)

1. Alper, C. A. and Rosen, F. S.: Studies of a hypo-morphic variant of human C3.J. clin. Invest. 50: 324-326(1971).
2. Bennett, W. M.; Bardana, E. J.; Wuepper, K.; Houghton, D.; Border, W. A.; Götze, O., and Schreiber, R.: Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J. Med. 62: 757-760 (1977).
3. Border W.; Wilson, C. B., and Gotze, O.: Nephritic factor: description of a new quantitative assay and findings in glomerulonephritis. Kidney int. 10: 311-318(1976)
4. Bronnestam, R.: Studies of C3 polymorphism. Re-lationship between phenotype and conversion rates in vitro. Hum. Hered. 23: 220-225 (1973).
5. Charlesworth J. D.: Williams, D. G.; Shcrington, E.; Lachmann, P. I., and Peters, D. K.: Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J. clin. Invest. 53: 1578-1587 (1974).
6. Daha M. R.: Austen, K. F., and Fearon D. T.: The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3hUb (C3NeF). and its release after decay of convertase function. J. Immun. 119: 812-817 (1977).
7. Davis, A. E.: Arnaout M. A.: Alper C. A., and Rosen F. S.: Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? New Engl J. Med. 297: 144-145 (1977).
8. Glass D.; Raum, D.: Gibson D.: Stillman J. S. and Shur P. H.: Inherited deficiency of the second component of complement. Rheumatic disease associations. J. clin. Invest. 58: 853-861 (1976).
9. Habib R.; Gubler, M. C; Loirat, C; Maize, H. B., and Levy, M.: Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney int. 7: 204-215 (1975).
10. McLean R. H.; Geiger, H.; Burke B.: Simmons, R.; Najarian, J.: Vernier, R. L., and Michael, A. F.: Recurrence of membranoproliferative glomerulonephritis following kidney transplantation. Am J. Med. 60: 60-72 (1976).
11. McLean, R.; Weinstein A.: Damjanov, I., and Rothfield N.: Hypomorphic variant of C3, arthritis and chronic glomerulonephritis. J. Pediat. 93: 937-943 (1978).
12. Peters, D. K. and Lachmann P. J.: Immunity deficiency in pathogenesis of glomerulonephritis. Lancet i: 58-60 (1974).
13. Sissons J. G. P.: Liebowitch J.; Amos N. and Peters, D K.: Metabolism of the fifth component of complement and its relation to metabolism of the third component, in patients with mmnlemenl artivntinn J Clin Invest 59-704-715 (1977).
14. Sissons J. G. P.; West R. J.; Fallows J.; Williams, D. G.; Boucher, B. J.: Amos N., and Peters, D. K.: The complement abnormalities of lipodystrophy. New Engl J. Med. 294: 461-465 (1975).
15. Teisberg P.: High voltage agarose electrophoresis in the study of C3 polymorphism. Vox Sang. 19: 47-56 (1970).
16. Thompson R. A.: C3 inactivation factor in thescrum of a patient with chronic hypocomplementemic proliferative glomerulonephritis. Immunology 22: 147-158 (1972).